Ocugen
OCGN· Manufacturing· Fiscal year ends in December
CEO pay in FY2025Stock +67.7% in FY2025
Shankar Musunuri, Ph.D., MBA is the CEO of Ocugen and was paid $4.8M in FY2025 (Dec), up 149%.
Pay$100 in the stock at the end of FY21 → $30
Executives4
See all- 1Shankar Musunuri, Ph.D., MBAChief Executive Officer, Chairman and Co-FounderFY2025
- 2Huma Qamar, M.D., MPH, CMIChief Medical OfficerFY2025
- 3Ramesh Ramachandran, CPA, MBA, CMAChief Accounting OfficerFY2025
- 4Arun Upadhyay, Ph.D.Chief Scientific OfficerFY2024
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allOcugen paid its 3 named executives $8.9M in total in FY2025 (Dec). CEO Shankar Musunuri, Ph.D., MBA was paid $4.8M of that.
| Name | |||
|---|---|---|---|
| Shankar Musunuri, Ph.D., MBAChief Executive Officer, Chairman and Co-Founder | |||
| Huma Qamar, M.D., MPH, CMIChief Medical Officer | Not disclosed | ||
| Ramesh Ramachandran, CPA, MBA, CMAChief Accounting Officer | Not disclosed | Not disclosed | |
| Arun Upadhyay, Ph.D.Chief Scientific Officer | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Ocugen. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board2
See all- Junge Zhang, Ph.DDirector · 6 yr on the boardIndependentCompensation, Nominating and Corporate Governance—Paid as an executive
- Satish ChandranDirector · 0 yr on the boardIndependentAudit, Compensation (Chair), Science and Technology—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 28, 2026 | FY2025 |
| Annual report | 10-K | Mar 4, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 25, 2025 | FY2024 |
| Annual report | 10-K | Mar 5, 2025 | FY2024 |
| Proxy statement | DEF 14A | May 28, 2024 | FY2023 |
| Annual report | 10-K | Apr 16, 2024 | FY2023 |
